| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
HC Wainwright & Co. analyst Kevin Dede upgrades Core Scientific (NASDAQ:CORZ) from Neutral to Buy and announces $25 pric...
Clear Street analyst Brian Dobson upgrades Core Scientific (NASDAQ:CORZ) from Hold to Buy and raises the price target from $...
Core Scientific (NASDAQ:CORZ) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0...
Core Scientific (NASDAQ:CORZ) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0...
Cantor Fitzgerald analyst Brett Knoblauch maintains Core Scientific (NASDAQ:CORZ) with a Overweight and raises the price tar...
Roth Capital analyst Darren Aftahi upgrades Core Scientific (NASDAQ:CORZ) from Neutral to Buy and raises the price target fr...